Differential utilization of metabolites and metabolic plasticity can confer adaptation to cancer cells under metabolic stress. Glutamine is one of the vital and versatile nutrients that cancer cells consume avidly for their proliferation, and therefore mechanisms related to glutamine metabolism have been identified as targets. Recently, sestrin2 (SESN2), a stress-inducible protein, has been reported to regulate survival in glutamine-depleted cancer cells; based on this, we explored if SESN2 could regulate glutamine metabolism during glucose starvation. This report highlights the role of SESN2 in the regulation of glutamine-dependent activation of the mitochondrial biogenesis marker peroxisome proliferator-activated receptor c coactivator 1a (PGC-1a) under glucose scarcity in liver cancer cells (HepG2). We demonstrate that down-regulation of SESN2 induces a decrease in the levels of intracellular glutamine and PGC-1a under glucose deprivation, concomitant with a decline in cell survival, but no effect was observed on the invasive or migration potential of the cells. Under similar metabolic conditions, SESN2 forms a complex with c-Jun N-terminal kinase (JNK) and forkhead box protein O1 (FOXO1). Absence of SESN2 or inhibition of JNK reduces nuclear translocation of FOXO1, consequently causing transcriptional inhibition of PGC-1a. Notably, our observations demonstrate a reduction in cell viability under high glutamine and low glucose conditions during SESN2 down-regulation that could be rescued on JNK inhibition. To recover from acetaminophen-induced mitochondrial damage, SESN2 was crucial for glutamine-mediated activation of PGC-1a in HepG2 cells. Collectively, we demonstrate a novel role of SESN2 in mediating activation of PGC-1a by modulating glutamine metabolism that facilitates cancer cell survival under glucose-limited metabolic conditions.
Introduction
Tumor cells mostly reside in a milieu where availability of nutrients such as glucose and oxygen is less than required [1] . To divide and proliferate under such adverse conditions is a formidable task that cancers accomplish by rewiring their biosynthetic metabolic pathways. Hence, to target these tumor cells, an understanding of the proteins involved in the molecular signaling that governs tumor cell adaptation and metabolic plasticity is essential. Glutamine is a metabolite that cancer cells utilize extensively for ATP production, biosynthesis of proteins, nucleotides, and lipids [2] . Glutaminolysis is one of the major anaplerotic pathways that have been reported to support cancer cell survival and growth by acting as a major energy source and regulating redox homeostasis [3, 4] . Evidence suggests that glutamine provides a chemoresistive advantage to cancer cells and its targeting has been suggested as a successful strategy [2, 3, 5] . However, lacunae in knowledge of glutamine-mediated metabolic reprogramming that can confer beneficial advantage to cancer cells limits such targeting. Hence, it is important to explore glutamine-dependent metabolic rewiring under adverse metabolic conditions. Studies have shown that under stress conditions such as hypoxia, glutamine consumption increases in most of the cancer cells for de novo lipogenesis [6] [7] [8] .
Peroxisome proliferator-activated receptor c coactivator 1a (PGC-1a) is a well-acknowledged stress sensor in cancer cells that promote mitochondrial biogenesis by regulating several transcriptional factors such as transcription factor A, mitochondrial (TFAM), and nuclear factor erythroid 2-related factor 2 (NRF2). Under metabolic stress conditions, activation of PGC-1a is known to be regulated by several other stress sensors such as AMP-activated protein kinase, Sirtuin 1, and p53 in cancer cells. Up-regulation of PGC-1a has been reported to provide chemo-resistance in cancer cells by limiting oxidative damage [9] . Recent reports show that activation of PGC-1a inhibits p53-mediated apoptosis induction and promotes cell growth by facilitating mitochondrial and fatty acid metabolism in liver cancer cells [10, 11] . Glutamine metabolism has been shown to be up-regulated by PGC-1a in breast cancer cells [12] , but whether glutamine metabolism modulates PGC-1a under metabolic stress is yet to be explored. Sestrins are conserved stress-inducible genes known to regulate mechanistic target of rapamycin (mTOR) and AMPactivated protein kinase signaling and has been suggested to play diverse roles in metabolism at various levels [13] . Inactivation of sestrins in Drosophila has demonstrated diverse metabolic pathologies ranging from oxidative stress to fat accumulation, muscle dystrophy, mitochondrial dysfunction, and reduction in cardiac function [14] . Ablation of SESN2 and SESN3 in mammalian cells has shown hyperactivation of mTOR signaling [15] and development of pathologies related to hepatic damage such as steato-hepatitis and fibrosis [16] . Other studies showed activation of SESN2 under hypoxia accompanied by glucose starvation inhibits necroptosis [17, 18] . Recently, SESN2 has been indicated as a leucine sensor that on binding with leucine releases GATOR2, resulting in activation of the mTOR pathway. Moreover, the same study also suggests SESN2 as a possible methionine sensor under leucine starvation, which may further influence mTOR activation [19] . Apart from acting as a leucine sensor, SESN2 has been recently reported to induce a positive feedback loop with mTORC2 for survival of glutamine-deprived cancer cells [20] . We enquired if SESN2 can induce metabolic reprogramming under glucose starvation (provided glutamine is abundant) in cancer cells and if so how that impacts PGC-1a levels.
Our findings suggest a positive regulation of glutamine metabolism and cell survival by SESN2 under glucose starvation in liver cancer cells. Under glucose starvation, SESN2 is activated, which in turn increases intracellular levels of glutamine and also increases levels of glutamine transporters LAT1 and ASCT2 on glutamine supplementation. Under glucose starvation, glutamine supplementation transcriptionally activates PGC-1a, which gets suppressed on down-regulation of SESN2. Interestingly, glucose-starved or glutaminesupplemented cells promote nuclear translocation of forkhead box protein O1 (FOXO1), which causes transcriptional activation of PGC1-a. Translocation of FOXO1 and transactivation of PGC-1a were both attenuated on down-regulation of SESN2. Furthermore, we detected that under similar metabolic conditions, c-Jun N-terminal kinase (JNK) promotes nuclear translocation of FOXO1, which subsequently mediates transcriptional activation of PGC1-a. Our findings also suggest SESN2 as a scaffold protein which interacts with both FOXO1 and JNK to regulate transcriptional activation of PGC-1a under glucose starvation, provided there is adequate availability of glutamine. In summary, these studies identify SESN2 as a novel modulator of PGC-1a in cancer cells under low availability of glucose by promoting utilization of glutamine.
Results

Sestrin2 increases intracellular glutamine transport under glucose starvation in HepG2 cancer cells
Cancer cells have elevated aerobic glycolysis and display increased dependency on glutamine for growth and proliferation [21, 22] . In glucose scarcity, which occurs due to heavy utilization of glucose by these fast-dividing cells, the cells rely on glutamine for fueling the TCA cycle for survival [23] . Arguably, therefore, cellular proteins essential for manipulating metabolism can be possible targets for conferring cell survival. Glucose starvation induces expression of one such protein, SESN2, which belongs to the sestrin family of stress-inducible proteins [13, 17] . Our ongoing studies have shown the involvement of SESN2 in maintaining mitochondrial homeostasis in cancer cells [24, 25] . In this investigation, using HepG2 cells, a human liver cancer cell line derived from a hepatocellular carcinoma [10] , we present a new finding on the involvement of SESN2 in glutamine-mediated metabolic reprogramming under glucose-deprived conditions through PGC-1a. The rationale for choosing HepG2 cells was the maximal inhibition of cell death in this cell line observed after glutamine supplementation in glucose-deprived conditions in comparison with seven other cancer cell lines (Fig. 1A) . Furthermore, Fig. 1 . Glutamine facilities survival of cancer cells under glucose-depleted conditions. (A) Analysis of cell death in HepG2 cells was done using propidium iodide (PI) assay. These cells were maintained under normal, low glucose (5 mM)/no glutamine, and high glutamine (10 mM)/low glucose (5 mM) culture conditions for 48 h. Error bars represent SEM (n = 3). P value represents comparison with low glucoselow glutamine condition. *P < 0.01, **P < 0.001, ## P < 0.005, ### P < 0.0005, NS, non-significant. (B) HepG2 cells cultured in high glutamine/low glucose medium for indicated time points and cell death measured using PI assay. Supplementation with fresh medium (Gln high/Glc low) was carried out after 48 h in one set and analysis was performed for next 24 h. Error bars represent SEM (n = 3). P value represents (red) comparison with non-supplemented group (60 and 72 h). $ P < 0.01. (C) HepG2 cells were transfected with scrambled siRNA (si Cont.) and three siRNAs targeting SESN2, and extent of SESN2 knockdown was analyzed by immunoblotting. (D) HepG2 cells were transfected with scrambled siRNA, siRNA targeting SESN2, and plasmid overexpressing SESN2. Overexpression of SESN2 was measured by western blotting. (E) Viability of wild-type, SESN2-knockdown, and SESN2-overexpressing cells was scored by PI assay under metabolic cultured conditions (24 h) as indicated. P value represents comparison with Glc low/Gln high. Error bars represent SEM (n = 3). *P < 0.01, NS, non-significant.
time-dependent analysis of viability of cultured HepG2 cells under low glucose/high glutamine (Glc low/Gln high) conditions showed that cell viability was significantly compromised after 48 h, which was rescued on re-supplementation of fresh media (Fig. 1B) . To assess the role of SESN2 in cell survival under low glucose/ high glutamine (Glc low/Gln high) conditions, SESN2 was knocked down by small interfering RNA (siRNA)-mediated silencing resulting in increased cell death in the SESN2-down-regulated cells as compared with scrambled siRNA transfected cells (Fig. 1C-E) . Overexpression of SESN2 in the knocked down cells reversed the effects of SESN2 down-regulation and reduced cell death in Glc low/Gln high conditions (Fig. 1E) . Furthermore, we found that down-regulation of SESN2 reduced proliferation potential of cells that were cultured under high glutamine/low glucose (Gln high/Glc low) metabolic conditions. Notably, knockdown of SESN2 in cells that were cultured in complete (normal) medium increased its clonogenic potential ( Fig. 2A) . Next, we explored if SESN2 down-regulation affects metastatic potential of cells under defined metabolic conditions. Our in vitro migration and invasion assay results showed that down-regulation of SESN2 did not alter migration and invasion potential of cancer cells under high glutamine and low glucose metabolic conditions (Fig. 2B,  C) . We also found that deprivation of either glutamine or glucose significantly reduced migration and invasion of cells, albeit more inhibition was observed on glucose deprivation defining essential role of glucose in governing metastatic potential of cancer cells (Fig. 2B,C) . To understand the mechanism of SESN2-mediated cell survival with respect to glutamine metabolism, the glutamine/glutamate conversion was checked in SESN2-down-regulated and overexpressed cells under high glutamine and low glucose conditions. Under SESN2 down-regulation, a substantial decline in intracellular glutamate levels prevailed while overexpression of SESN2 restored intracellular glutamate levels (Fig. 2D) . Under similar metabolic conditions, glutamine levels dropped upon SESN2 down-regulation, but a significant restoration was observed upon SESN2 overexpression (Fig. 2E) . As a positive control, bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES), a glutaminase (GLS1) inhibitor, was used, and BPTES treatment resulted in lowering of glutamate levels with intracellular accumulation of glutamine (Fig. 2F,G) showing accumulation of glutamine when conversion of glutamine to glutamate was blocked. Therefore, a decrease in intracellular glutamate levels on SESN2 down-regulation without concomitant accumulation of glutamine levels suggested no effect of SESN2 on the conversion of glutamine to glutamate. However, SESN2 could possibly influence glutamine levels through other mechanisms. Basal levels of reduced glutathione (GSH) were found to be substantially increased in wild-type cells that were cultured in high glutamine/low glucose as compared with normal medium. A significant reduction in intracellular levels of GSH was observed on down-regulation of SESN2 that was rescued on SESN2 overexpression, suggesting a possible role of SESN2 in glutaminedependent redox homeostasis under glucose limitation (Fig. 2H) . In summary, these data suggested the involvement of SESN2 in the regulation of glutamine metabolism and cell survival under high glutamine and glucose-starved conditions. Sestrin2 promotes glutamine-mediated increase in levels of PGC-1a under glucose starvation
Since the above data showed the involvement of SESN2 in glutamine metabolism, we sought to explore if SESN2 influenced PGC-1a, which is known to regulate glutamine metabolism and mitochondrial biogenesis [12] . Both protein and mRNA levels of PGC-1a were up-regulated in the Gln high/Glc low metabolic state while reduced levels were observed under Glc high/Gln low cultured conditions (Fig. 3A-D) , suggesting that high glutamine conditions favored higher expression of PGC-1a. An increase in SESN2 mRNA and protein levels was detected under both high glucose and high glutamine conditions (Fig. 3A,B,D) . SESN2 down-regulation was more effective in reducing PGC-1a levels specifically under Gln high/Glc low metabolic conditions (Fig. 3E) . To reconfirm the role of SESN2 in PGC-1a regulation, we used SESN-triple (SESN 1, 2, 3) null cells (TKO cells) that were cultured in low glucose medium and glutamine was supplemented in increasing concentrations. Addition of increasing concentrations of glutamine in low glucose and SESN2 null conditions led to an increase in PGC1a levels (Fig. 3F ). This suggested that the level of PGC-1a was dependent on SESN2 in cells under abundant glutamine and low glucose conditions. It was possible that lowering of PGC-1a levels under SESN2 down-regulation could be due to increased proteasome-mediated degradation of PGC1-a, but when MG132, a proteasome inhibitor, was used in SESN2-down-regulated or WT cells, no effect on PGC-1a levels was observed (Fig. 3G) . In SESN triple-null cells under Gln high/Glc low conditions, the PGC-1a mRNA level was low compared with wildtype cells ( Fig. 3H ; Table S1 ). The level of PGC-1a mRNA was higher when SESN2 was overexpressed (Fig. 3H) , clearly suggesting that levels of SESN2 influenced transcription of PGC1-a. To check this under altered glucose and glutamine conditions, mRNA was estimated from SESN2-knockdown HepG2 cells where glucose and glutamine levels were modified. In Glc high/Gln low conditions, the mRNA levels of PGC-1a in WT and SESN2 knocked-down cells were comparable (Fig. 4A) ; however, PGC-1a mRNA levels increased under Gln high/Glc low conditions in WT cells while a substantial decrease in mRNA levels was observed on SESN2 downregulation ( Fig. 4A ; Table S1 ). The expression of TFAM, which is a transcriptional target of PGC1-a, was also up-regulated in Gln high/Glc low metabolic conditions while knockdown of SESN2 resulted in its down-regulation ( Fig. 4A ; Table S1 ). Furthermore, down-regulation of SESN2 under Gln high/Glc low metabolic condition also resulted in reduction in the gene expression of phosphoenolpyruvate carboxykinase (PEPCK), which is involved in gluconeogenesis, while no significant variation was observed in the glycolytic gene for hexokinase II (Fig. 4B) . Notably, we observed a significant increase in gene expression of pro-apoptotic factors, p53 up-regulated modulator of apoptosis (PUMA) and BAX on down-regulation of SESN2 under Gln high/Glc low metabolic conditions (Fig. 4C ). Since SESN2 was influencing PGC1-a, it was important to analyze its effect on mitochondrial biogenesis. Mitochondrial mass was measured by staining with MitoTracker Green FM, and we observed that the content of mitochondria in cells was less in the presence of low glucose (Glc low/Gln low), which substantially increased on supplementation with adequate glutamine (Gln high/Glc low) (Fig. 4D ). The mitochondrial content was even less in the presence of high glucose (Glc high/Gln low), which was increased in high glutamine (Gln high/Glc low) conditions (Fig. 4E) . Furthermore, analysis of mitochondrially encoded genes for cyclooxygenase (COX) II, COX IV, and cytochrome c under Gln high/Glc low metabolic conditions showed a significant reduction in SESN2-knockdown cells that was restored on SESN2 expression (Fig. 4F) . A significant reduction was observed in mitochondrial content on SESN2 down-regulation that was restored on its expression (Fig. 4G) . Analysis of ATP levels in HepG2 and PANC1 cells showed a decline on down-regulation of SESN2, suggesting reduced mitochondrial activity on SESN2 knockdown (Fig. 4H,I ). Therefore, results from this part of the investigation show that SESN2 regulates transcriptional activation of PGC-1a and mitochondrial biogenesis while inhibiting expression of pro-apoptotic genes in HepG2 cells under Gln high/Glc low metabolic conditions, possibly favoring survival.
Sestrin2 increases levels of glutamine transporters ASCT2 and LAT1 under glucose starvation
In a wide variety of cancer cells, the expression levels of amino acid transporters ASCT2 and LAT1 are elevated to support tumor metabolism [26] . We found that in SESN2-down-regulated cells, the level of these transporters was reduced in Gln high/Glc low metabolic conditions (Fig. 5A,B) . With overexpression of SESN2, the expression of PGC1-a, LAT1 and ASCT2 increased suggesting a requirement of SESN2 levels to support expression of PGC-1a and the transporters (Fig. 5C ). The supplementation of glucose under Gln high/Glc low conditions decreased both SESN2 and PGC-1a levels as well as the levels of glutamine transporters ASCT2 and LAT1 (Fig. 5D ). Under high glucose conditions, levels of PGC-1a were reduced; however, we observed an upregulation on low-dose supplementation of glutamine (29, 4 mM). Furthermore, addition of glutamine (59 and 109) under high glucose conditions reduced the level of PGC1-a, ASCT2, and LAT1 ( Fig. 5E,F) . Supplementation of limited metabolites, glucose, or glutamine (albeit the other metabolite is adequate) showed an increase in activation of mTORC1 signaling, scored by phosphorylation of S6K (Fig. 5D ,E). Down-regulation of SESN2 under Gln high/Glc low conditions showed a significant activation of mTORC1. Interestingly, activation of mTORC2, measured by AKT phosphorylation (S473 and T450), was decreased on SESN2 down-regulation, which was restored on SESN2 expression (Fig. 5G ). These results suggest that SESN2 In vitro scratch migration assay was performed in wild-type and SESN2-knockdown cells that were cultured in defined metabolic conditions and analysis was performed after 12 h. Bar graph represents mean AE SEM of three independent experiments. P value represents comparison with negative (Àve) control in wild-type and SESN2-knockdown cells. *P < 0.01, **P < 0.001, # P < 0.05. (C) In vitro transwell cell invasion assay was performed in wildtype and SESN2-knockdown cells that were cultured in defined metabolic conditions and analysis was performed after 16 h. Cells in transwell inserts were serum starved for 6 h before plating. Bar graph shows quantification of migrated cells and represents mean AE SEM of three independent experiments. P value represents comparison of wild-type vs SESN2 cells in each group. Àve control, no serum in lower chamber. NS, non-significant. (D) Analysis of intracellular glutamate levels was done in HepG2 wild-type (WT), SESN2-knockdown (siSESN2), and SESN2-overexpressing (OE-SESN2) cells after 24 h of culturing in high glutamine/low glucose medium. Error bars represent SEM (n = 3). P value represents comparison with wild-type. *P < 0.01, # P < 0.05. (E) Intracellular glutamine levels were measured with same experimental set-up as indicated in Fig. 2D . Error bars represent SEM (n = 3). P value represents comparison with wild-type. **P < 0.001, # P < 0.05. (F) Intracellular glutamate levels were analyzed in HepG2 wild-type (WT), SESN2-knockdown (siSESN2), and SESN2-overexpressing (OE-SESN2) cells and wild-type cells were treated with BPTES as indicated. Error bars represent SEM (n = 3). P value represents comparison with wild-type. *P < 0.01, **P < 0.001, increases PGC-1a levels under glucose starvation possibly by influencing levels of ASCT2 and LAT1, providing adequate availability of glutamine. Therefore, the data presented in this section provide evidence for SESN2-mediated increase in glutamine transporters under glucose starvation. (24 h). Since the experiments are the same, the actin loading control is identical to the blot shown in Fig. 5A as they were derived from the same lysates. (F) Western blot analysis of protein levels of PGC-1a was performed in SESN triplenull HEK293T (TKO) cells that were cultured in low glucose (5 mM) medium. GlutaMax was supplemented with an increase in concentration (09 to 59) as indicated for 24 h and HA-tagged SESN2 was expressed in TKO cells; 19 GlutaMax = 2 mM glutamine. (G) HepG2 wild-type and SESN2-down-regulated cells were cultured in Glc high/Gln low medium for 24 h and MG132 treatment was given as indicated. Immunoblot analysis of PGC-1a levels was performed. (H) Wild-type, TKO, and HA-tagged SESN2-expressing TKO cells were cultured in Glc high/Gln low medium for 24 h and gene expression of PGC-1a was measured by quantitative real-time PCR. Western blot shows levels of PGC1-a in the experiment. Error bars represent SEM (n = 3). P value represents comparison with wild-type. *P < 0.01.
Sestrin2 facilitates JNK-dependent nuclear translocation of FOXO1, which mediates transactivation of PGC1-a PGC-1a expression is modulated in response to a variety of stimuli by a number of transcription factors [27] . Having established that SESN2 regulates PGC-1a expression, we tested under Gln high/Glc low conditions nuclear translocation of a number of transcription factors that could influence transcription of PGC1-a. Of the five transcription factors, p53, cAMP response element-binding protein (CREB), FOXO1, FOXO3a and nuclear factor jB (NFjB), translocation of FOXO1 was drastically inhibited in SESN triple- null cells. However, overexpression of SESN2 in these cells rescued nuclear translocation of FOXO1 in Gln high/Glc low conditions, suggesting that its translocation to the nucleus was dependent on Sestrin2 (Fig. 6A) . These results were confirmed in PANC1 cells where SESN2 down-regulation resulted in lesser FOXO1 translocation to the nucleus suggesting less PGC-1a expression (Fig. 6B,C) . At this juncture, the upstream elements necessary for the nuclear translocation of FOXO1 had to be identified. Four stress response kinases, extracellular signal-regulated kinase (ERK), JNK, p38 mitogen-activated protein kinase (MAPK), and AKT were inhibited with relevant inhibitors; it was only the inhibition of JNK that markedly inhibited the nuclear translocation of FOXO1 (Fig. 6D,E) . Notably, an inhibition in PGC-1a expression was observed on JNK inhibition that failed to be restored on overexpression of SESN2, suggesting that JNK activation was essential for FOXO1-mediated transactivation of PGC-1a (Fig. 6F ).
To explore how SESN2 regulated JNK-mediated nuclear translocation of FOXO1, we first checked if SESN2 could influence levels of JNK and FOXO1. There was no significant variation in JNK or FOXO1 levels on down-regulation of SESN2, but a significant increase in phosphorylation of JNK was observed on SESN2 knockdown (Fig. 7A) . Earlier studies have shown interaction of SESN2 with JNK [28] . We found that in Gln high/Glc low conditions, SESN2 significantly interacted with both FOXO1 and JNK; however, a lesser interaction was observed in glucose-rich and glutamine-starved cells (Fig. 7B) . Furthermore, a reduced interaction between FOXO1 and JNK was observed in SESN triple-null cells, whereas SESN2 overexpression promoted FOXO1 and JNK interaction, clearly suggesting that SESN2 is necessary for the regulation of interaction between FOXO1 and JNK (Fig. 7C) . Furthermore, analysis of nuclear and cytosolic fractions showed a substantial decline in nuclear translocation of FOXO1 in SESN2-knockdown and JNK-inhibited cells. Overexpression of SESN2 failed to restore the nuclear translocation of FOXO1 showing the requirement of JNK activation in translocation (Fig. 7D) . Interestingly, we observed that SESN2 knockdown compromised cell viability under glucose starvation (Gln high/Glc low), which was rescued on inhibition of JNK, indicating that SESN2 might be responsible for restricting the prodeath axis of JNK (Fig. 7E) . In summary, these data show that SESN2 assists in the nuclear translocation of FOXO1 by governing the interaction between JNK and FOXO1.
Sestrin2-mediated glutamine metabolism protects against acetaminophen-induced mitochondrial damage and induces PGC-1a expression
Glutamine is known to maintain redox homeostasis [29] . Acetaminophen has been reported to disrupt this, thereby increasing the chemotherapeutic potential of anti-cancer drugs in hepatic cancer cells [30, 31] . To determine the functional involvement of SESN2-modulated glutamine metabolism, we used a system of acetaminophen (APAP)-induced cell death mediated through mitochondrial dysfunction [32] [33] [34] . Knockdown of SESN2 significantly enhanced mitochondrial depolarization in both untreated and APAP-treated HepG2 cells under Glc low/Gln high conditions, which was substantially attenuated on overexpression of SESN2 suggesting it has a cytoprotective role (Fig. 8A) . Furthermore, analysis of intracellular levels of reduced glutathione showed that the SESN2 downregulation severely aggravated APAP-induced depletion of the GSH pool. Reduction in APAP-induced GSH levels was rescued on SESN2 expression (Fig. 8B) . APAP treatment (cells cultured in Gln high/ Glc low medium) mildly enhanced intracellular glutamate levels in wild-type HepG2 cells, which significantly declined on down-regulation of SESN2. Overexpression of SESN2 restored intracellular glutamate levels, suggesting that SESN2 enhanced glutamine metabolism upon mitochondrial damage induced by APAP (Fig. 8C) . The next question was, does SESN2-regulated glutamine metabolism influence PGC-1a levels during recovery from APAP treatment? Cells cultured in normal medium (Gln high/Glc high) treated with APAP for 6 h and allowed to recover for the next 6 h in Gln high/Glc low medium showed a linear increase in PGC-1a levels (Fig. 8D) . Notably, APAP treatment decreased levels of PGC-1a while recovery of cells resulted in an increase in the levels of glutamine transporters ASCT2 and LAT1 during the recovery phase (Fig. 8E) . We also found that phosphorylation of JNK was increased on APAP treatment, which was attenuated in the recovery phase in a linear manner. Down-regulation of SESN2 during the recovery phase severely hampered the increase in PGC-1a levels while overexpression of SESN2 promoted the increase in levels of PGC-1a (Fig. 8F) . Notably, downregulation of SESN2 increased phosphorylation of JNK while overexpression reduced phosphorylation of JNK. Furthermore, knockdown of SESN2 significantly increased cell death in untreated and APAP-treated HepG2 cells under Gln high/Glc low metabolic conditions. Inhibition of JNK activation resulted in substantial restoration of cell viability in SESN2-down- Wild-type, TKO, and HA-SESN2-expressing TKO cells were culture in indicated metabolic state. Nuclear and cytosolic fractions were isolated, and immunoblotting was performed to measure level of indicated proteins. (B) PANC1 wild-type, SESN2-knockdown, and -overexpressing cells were cultured in Gln high/Glc low medium. Nucleus vs cytosolic fractions were analyzed for FOXO1. (C) PANC1 wild-type and SESN2-knockdown cells were cultured in Gln high/Glc low medium and PGC-1a levels were measured by immunoblotting. (D) Inhibitors of AKT, p38 MAPK, ERK, and JNK were used in HepG2 cells that were cultured in Gln high/Glc low medium and confirmation of inhibition was performed by western blot. Specificity of inhibitors was confirmed by performing phospho-AKT (S473) and phospho-AKT (T308) blots post ERK, p38, and JNK inhibition respectively. (E) HepG2 cells were grown in Gln high/Glc low medium and specific inhibitors for AKT (LY), ERK (PD), JNK (SP), and p38 MAPK (SB) were used. Nuclear and cytosolic fractions were isolated and immunoblotting was performed to measure FOXO1 translocation. LY, LY294002 (10 lM); PD, PD98059 (10 lM); SB, SB203580 (20 lM); SP, SP600125 (20 lM). (F) Wild-type, SESN2-down-regulated, and HA-tagged SESN2-expressing HepG2 cells were treated with JNK inhibitor (SP600125) and gene expression of PGC-1a was quantified by quantitative real-time PCR. Error bars represent SEM (n = 3). P value represents comparison with wild-type. *P < 0.01, ## P < 0.005. regulated cells (Fig. 8G) , suggesting activation of JNKmediated apoptosis under SESN2 down-regulation, hence supporting our findings presented in Fig. 7E .
Mito-Tempo (a mitochondrial superoxide specific quencher) was also able to attenuate the APAPinduced extent of mitochondrial depolarization both in Fig. 7 . Sestrin2 forms a complex with JNK and FOXO1 under glucose deprivation that facilitates JNK and FOXO1 interaction. (A) Wild-type and SESN2-knockdown HepG2 cells were cultured in Gln high/Glc low medium and immunoblotting was performed to measure the levels of indicated proteins. Densitometry measurements show relative intensity of phosphorylated-JNK. Error bars represent SEM (n = 3). P value represents comparison with wild-type. *P < 0.01. (B) Wild-type and HA-SESN2-expressing HepG2 cells were cultured in Glc low/Gln low, Glc high/Gln low, and Gln high/Glc low media (as indicated). Co-immunoprecipitation assay was performed using HA antibody and immunoblotting was done with JNK and FOXO1 antibody. (C) Co-immunoprecipitation assay was performed in wild-type, TKO, and HA-tagged SESN2-expressing TKO cells using FOXO1 antibody and immunoblotting was done for JNK. (D) Wild-type, SESN2-down-regulated and HA-tagged SESN2-expressing HepG2 cells were cultured in Gln high/Glc low medium for 24 h and treated with JNK inhibitor (20 lM SP600125). Nuclear and cytosolic fractions were isolated and immunoblotting was done to check localization of FOXO1. (E) Under same experimental set-up as Fig. 7D , cell death was analyzed using PI assay. Error bars represent SEM (n = 3). P value represents comparison with wild-type. *P < 0.01.
wild-type and SESN2-down-regulated cells (Fig. 8H) . Together, these results suggest that Sestrin2 is a positive regulator of PGC-1a that confers survival and helps cancer cells to recover from APAP-induced mitochondrial damage under glucose-starved conditions.
Discussion
Dependency on glutamine is preponderant in cancer cells, favoring their growth and proliferation [2] . It is essential to understand the functions of specific Wild-type, SESN2-down-regulated, and HA-tagged SESN2-expressing HepG2 cells were cultured in Gln high/Glc low medium and treated with DMSO or APAP, and intracellular levels of glutamate were measured. Error bars represent SEM (n = 3). P value represents comparison with wild-type. *P < 0.01, **P < 0.001, proteins regulating events that dictate cellular processes in cancer cells living in a metabolic milieu different from normal cells. Recently, Sestrin2 was shown to be up-regulated in response to glutamine deprivation resulting in the rescue of cell death through suppression of mTORC1 activation [20] . Sestrin2 is a member of a stress-inducible family of proteins that are activated under a diverse range of stressors such as hypoxia, oxidative stress, DNA damage, glucose starvation, and nutrient deprivation [17, 18, 35, 36] . Earlier studies have shown SESN2 activation in glucose-deprived conditions in a PGC-1a-dependent manner [10] . We present new findings in this report demonstrating the role of Sestrin2 in regulation of survival of cancer cells under glucose starvation.
The observation of up-regulated SESN2 in glucosedeprived conditions corroborates previous data reported in human lung adenocarcinoma cells [17] . However, in that study, the role of SESN2 under glutamine-rich conditions was not explored although a high glutamine level is favored by cancer cells and therefore it is important to understand it. With the hypothesis that since Sestrin2 is a stress response protein that could respond to altered conditions in cancer cells and regulate important events, we examined its functional role in high glutamine conditions. Consistent with earlier findings, it was observed that SESN2 acts as a tumor suppressor under normal metabolic conditions and negatively regulates the proliferative potential of cancer cells [37] . However, its tumor suppressive potential is altered under glucose limitation where SESN2 promotes the growth of cancer cells by modulating glutamine metabolism. Notably, down-regulation of SESN2 was unable to alter the invasion and migration properties of tumor cells under defined metabolic conditions. The decrease in intracellular levels of both glutamine and glutamate under SESN2-down-regulated conditions and their increase post-SESN2 overexpression indicated that Sestrin2 did have a link to the glutamine levels in cells, but certainly it did not regulate the conversion of glutamine to glutamate because there was no accumulation of glutamine, which would have normally occurred if the conversion of glutamine to glutamate was blocked. A recent study has shown that SESN2 promotes survival of cancer cells by inhibiting mTORC1 and activating mTORC2 signaling under depletion of glutamine [20] . Our studies showing silencing of SESN2 expression under glucose limitation (adequate glutamine) negatively regulating mTORC2 while activating mTORC1 suggests that under differential metabolic stressors, SESN2 may act as a sensor that promotes cancer cell survival by positively regulating mTORC2, which in turn regulates mTORC1. However, extensive studies are required to understand the mechanism involved in the process. Glutamine metabolism is regulated by multiple factors, and one of them is via the PGC-1a [9] . Our observations of low PGC-1a levels in triplenull SESN-knockout cells or SESN2-knockdown cells but higher levels after SESN2 overexpression clearly indicated a link between PGC-1a and SESN2. The importance of the metabolic state of cells for the regulation of PGC-1a was evident from the data showing low levels of PGC-1a under high glucose and low glutamine conditions, whereas high glutamine and low glucose conditions showed higher PGC1-a. The increase in PGC-1a levels in triple knockout SESN cells under SESN2 overexpression with increasing concentrations of glutamine confirms that an adequate amount of glutamine is required for SESN2-mediated increase in PGC-1a expression. Moreover, a prominent reduction in levels of PGC-1a on SESN2 knockdown under high glutamine conditions but not under high glucose conditions confirms the dependency of SESN2-mediated regulation of PGC-1a on the presence of adequate glutamine as is prevalent in cancer cells. PGC-1a has been reported to positively regulate glutamine metabolism and higher levels have been correlated with reduced patient survival [12] . On the other hand, high glutamine has been reported to up-regulate mitochondrial biogenesis and PGC-1a levels [38] . Our results from live cell imaging show that SESN2 up-regulates PGC-1a-mediated mitochondrial biogenesis. The observed elevation in the expression levels of amino acid transporters ASCT2 and LAT1 on SESN2 overexpression and low expression levels when SESN2 was down-regulated suggested the glutamine regulation at the level of transportation. Elevation in the expression levels of amino acid transporters ASCT2 and LAT1 to support tumor metabolism is widely known [26] and our studies indicate a SESN2-mediated regulation of expression of these transporters. The mechanistic regulation of this process requires detailed study.
Since from the above data, it was very clear that Sestrin2 was regulating the PGC-1a levels under high glutamine conditions, the question was whether it was through post-translational modification of PGC-1a. In contrast to observations under prolonged glucose starvation where RNF2-mediated ubiquitination of PGC1a was observed [10] , our studies demonstrate less transcriptional activation of PGC-1a on down-regulation of SESN2 instead of increased ubiquitination under low glucose and high glutamine in HepG2 cells. The obvious question was how SESN2 regulates PGC-1a transcription. Earlier studies have shown FOXO1 to be one of the factors that bind upstream of the PGC-1a promoter and mediate its transcription [27] . Our studies showing lesser nuclear translocation of FOXO1 during inhibition of SESN2 under Gln high/Glc low nutrient conditions indicated a possible role of SESN2 in FOXO1 regulation during the transcription of PGC1-a. Since re-expression of SESN2 rescued the nuclear translocation of FOXO1, it reiterated a functional participation of SESN2 in the event. Prior knowledge of JNK, being a critical regulator of SESN2 [36, 39] , prompted us to check the effects of pharmacological inhibitors of AKT, JNK, p38 MAPK, and ERK signaling on FOXO1. Since only JNK inhibition under glucose starvation resulted in suppression of FOXO1 nuclear translocation, we further attempted to look into interactions between FOXO1, JNK, and Sestrin2. The observed complex formation between FOXO1, JNK, and Sestrin2 revealed by immunoprecipitation studies clearly suggested why SESN2 downregulation reduced PGC-1a transcription, as deprivation of SESN2 resulted in a lesser interaction between JNK and FOXO1, disrupting the transcription initiation machinery. Studies using C. Elegans have shown that JNK positively regulates the life span of worms by enhancing nuclear translocation of the ortholog of mammalian FOXO, DAF-16 [40, 41] . FOXO1 has been demonstrated to activate PGC-1a and vice versa [42] . PGC-1a is known for co-activation of FOXO1 during insulin-regulated gluconeogenesis [43] . The role of JNK in apoptosis is well known [44, 45] but contrasting reports have also suggested JNK as a pro-survival protein [46, 47] . Since increased cell death under SESN2 down-regulation was attenuated on inhibition of JNK, the possibility that the presence of Sestrin2 may act as a switch for JNK-mediated activation of the prosurvival axis was evident.
Glutamine-mediated metabolic reprogramming has been reported to be exploited by many cancer cells as a protection mechanism to acquire chemo-resistance [5] . Acetaminophen was reported to perturb glutaminemediated redox status, thereby enhancing the chemotherapeutic response in hepatic cancer cells [29] [30] [31] . Acetaminophen is also known to induce liver injury and has cytotoxic effect on HepG2 cells [34, 48] . Recently, Sestrin2 has been reported to provide protection against APAP-mediated liver damage [49] . In conformity with the above report, our study showed a functional involvement of Sestrin2-modulated glutamine metabolism in recovery from APAP-induced cell death via mitochondrial damage [32] [33] [34] under glucose-deprived (glutamine rich) conditions in hepatic cancer cells. Glutamine has been reported to ameliorate severe APAP-induced hepatic injury [50] . Importantly, SESN2 down-regulation severely impaired increase in PGC-1a levels during rescue of APAP-induced damage under Gln high/Glc low nutrient conditions.
Taken together, we propose a mechanistic model based on our findings in which Sestrin2 serves as an important player in the regulation of transcriptional activation of PGC-1a-mediated mitochondrial biogenesis and survival of liver cancer cells by modulating glutamine metabolism under glucose limitations. This work opens up questions for further investigation on the mechanism of ASCT2 and LAT1 involvement in SESN2-mediated PGC-1a modulation. Furthermore, our observations suggest Sestrin2 as a scaffold protein interacting with JNK and FOXO1 facilitating FOXO1 nuclear translocation and consequently the activation of PGC1-a. SESN2-mediated glutamine utilization also provides cellular protection against APAPinduced hepatic damage possibly by limiting the prodeath effects of JNK.
Materials and methods
Cell lines, culture conditions, and reagents
All the cell lines (HeLa, MCF7, PANC1, HepG2, HEK293T, HC116, H1299, and SH-SY5Y) were purchased from ATCC (Manassas, VA, USA). A triple-null SESN cell line was generated by Crisper/Cas9 in D. M. Sabatini's laboratory (Whitehead Institute, USA). Cells were maintained in media as per instructions from ATCC. Dulbecco's modified Eagle's medium was purchased from Sigma-Aldrich (St Louis, MO, USA; cat. no. D6046). Glutamine-and glucose-less DMEM medium was purchased from Thermo Fisher Scientific (Waltham, MA, USA; A1443001). Glucose and glutamine were added as per experimental requirements. For glutamine supplementation, Glutamax (Thermo Fisher Scientific; 35050061) was used. Dynabeads Protein G (Thermo Fisher Scientific; 1000D) and Dynabeads Immunoprecipitation Kit (10007D) were purchased from Thermo Fisher Scientific; 10% heat-inactivated fetal bovine serum was from Biological Industries (Cromwell, CT, USA), Mito-Tempo was from Enzo Life Sciences (Farmingdale, NY, USA; ALX-430-150-M005), CBX protein assay kit was from G-Biosciences (St Louis, MO, USA; 786-12X), ECL Clarity kit was from Bio-Rad Laboratories (Hercules, CA, USA; 170-5061) and Lipofectamine LTX-3000 was from Thermo Fisher Scientific (L3000015). Nitrocellulose membrane (HATF00010) was purchased from Merck Millipore Ltd (Burlington, MA, USA). Inhibitors for JNK (SP600125), p38 MAPK (SB203580), ERK (PD98059) and AKT (LY294002) were purchased from Cell Signaling Technology (Danvers, MA, USA). Colorimetricbased glutamate detection kit (MAK004) was obtained from Sigma-Aldrich and a glutamine detection kit (K556) was purchased from Biovision (Milpitas, CA, USA). Unless otherwise mentioned, all other chemicals used for experiments were purchased from Sigma-Aldrich). 
Antibodies
Plasmids and siRNA
The siRNA no. 1 targeting SESN2 (SR313205) was purchased from Origene (Rockville, MD, USA); siRNA no. 2 silencer select targeting SESN2 (S38099) was purchased from Thermo Fisher Scientific; siRNA no. 3 (ON-TARGETplus and SMARTpool, which is a mixture of four siRNAs in a single reagent) targeting SESN2 (L-019134-02) was purchased from GE Dharmacon (Lafayette, CO, USA). HA-tagged SESN2 plasmid was purchased from Addgene (Cambridge, MA, USA).
Transfection
For siRNA transfections, low passage cells were transfected using the N-TER peptide transfection kit (Sigma-Aldrich; N2913). To achieve efficient knockdown of a gene, post-36 h of first transfection, cells were again transfected using the same method and cells with ≥ 90% down-regulation efficiency were used for the experimental set-up [51] . For transfection of plasmids, cells were seeded 24 h prior to transfection and were transfected using Lipofectamine LTX (Thermo Fisher Scientific) at a concentration of 2% of culture medium.
Western blotting
Whole cell lysates were prepared using 19 sample buffer containing 2% SDS, 10% glycerol, 0.1% 2-mercaptoethanol, and 100 mM Tris/HCl (pH 6.8) and estimation of proteins was done using a CBX assay kit. Equal amount of protein samples were loaded and resolved on 12% SDS/PAGE gel and subsequently transferred onto nitrocellulose membrane as described previously [52] . Furthermore, transblotted proteins were blocked using 5% BSA and immunoblotting was done using relevant primary and secondary antibodies. Analysis of results was done with an ECL Clarity kit (Bio-Rad; 170-5061) and autoradiography using X-ray film. Quantification of density of signals on immunoblots was performed using GENE TOOLS software (Syngene, Cambridge, UK).
Co-immunoprecipitation
Pull-down assays from whole cell lysates were performed with indicated antibodies using Dynabeads Protein G Immunoprecipitation kit following the protocol as mentioned previously [24] . In brief, 5 9 10 7 cells were transfected using the required siRNA or plasmid constructs and lysed in lysis buffer containing 20 mM HEPES, 100 mM NaCl, 1% Triton X-100, 150 mM NaCl, 20 mM Tris (pH 7.5), 0.5 mM PMSF, 0.5 mM EDTA and protease inhibitors (Roche, Basel, Switzerland). After sonication and incubation (4°C, 30 min), cell lysates were centrifuged and supernatants were collected (20 min, 15 000 g, 4°C). The concentration of lysates was measured using the CBX assay kit, and 800-1000 lg of lysate protein was used for coimmunoprecipitation using the Dynabeads Protein G Immunoprecipitation kit. IgG isotype antibodies were used as negative control. To avoid heavy/light chain inference, true blot secondary antibodies were used for detection.
Nuclear vs cytosolic fractionation
Isolation of cytosolic and nuclear fractions was done using the NE-PER nuclear and cytosolic fractionation kit (Promega, Madison, WI, USA; 78833) with following the manufacturer's instructions. In brief, 2 9 10 7 cells were harvested using trypsin-EDTA and washed with PBS. Cells were lysed using ice-cold CER-I reagent and cytosolic and nuclear fractions were isolated using CER-II and NER-II reagents. Purity of fractions was analyzed in immunoblotting using appropriate nuclear and cytosolic markers.
Measurement of intracellular levels of glutamine and glutamate
Intracellular levels of glutamine (K556, Biovision) and glutamate (MAK004, Sigma-Aldrich) were analyzed by a colorimetric detection assay kit using the manufacturer's protocol. The measurement of absorbance was done at 450 nm using a CLARIOstar multi-mode microplate reader (BMG Labtech, Ortenberg, Germany).
Measurement of cell viability and cell death
Cell viability was measured using a PI assay as described previously [53] and analysis was done using a CLARIOstar multi-mode microplate reader.
Measurement of ATP
Intracellular ATP levels were determined using the manufacturer's protocol (A22066, Thermo Fisher Scientific). Measurement of luminescence was done using a CLARIOstar multi-mode microplate reader at emission 568 nm.
Measurement of GSH levels
Measurement of intracellular levels of GSH was performed as mentioned previously [53] . Briefly, samples from homogenized cells were mixed with 1 M trichloroacetic acid redox quenching buffer and 0.1 M potassium phosphate buffer (pH 8) (1 : 4 ratio). Following this, 5.5 mM o-phthalaldehyde was added and incubated for 5 min at room temperature. Fluorescence was measured at 360 nm (excitation) and 430 nm (emission) using a CLARIOstar multi-mode microplate reader.
Clonogenic assay for cell proliferation
Cells were harvested and 10 3 cells were plated in a six-well plate with appropriate medium as per required in the study. Colonies in each well were stained with crystal violet and counted after 14 days of culture.
Invasion and migration assays
In vitro scratch assay Cells (2 9 10 5 ) were plated in a 24-well plate in different media as per the requirement of the experiment; 16 h later, using a sterile 200 lL pipette tip, a vertical wound was made and wound closure was imaged after 16 h using an inverted microscope.
Transwell cell migration and invasion assay
Cells were cultured in serum-free medium for 6 h before plating for the assay. Cells (5 9 10 4 ) were plated in 24-well hanging cell culture transwell inserts (Millipore, Billerica, MA, USA; MCEP24H48) and medium with serum was added in the lower chamber. After 16 h, transwell inserts were removed and fixed with 70% ethanol. The transwell inserts were stained using 0.5% crystal violet and imaging was done using an inverted microscope. Invasion percentage was calculated as (number of cells per insert/total number of cells seeded in the insert) 9 100.
Analysis of mitochondrial biogenesis
Mitochondrial content was measured by evaluating levels of the mitochondrial proteins COX IV and cytochrome c and staining cells with MitoTracker Green FM (M7514, Thermofisher Scientific). Measurement of the fluorescence intensity of the MitoTracker Green FM was made with a CLARIOstar filter-based multi-mode microplate reader.
Determination of depolarization of mitochondria in cells
Mitochondrial membrane potential was determined using an anionic (lipophilic) mitochondrial JC-1 dye (5,5 0 ,6,6 0 -tetrachloro1,1 0 ,3,3 0 -tetraethylbenzimidozolylcarbocyanine iodide; Thermo Fisher Scientific; T-3168) as described previously [53] . In brief, cells were harvested and incubated for 15 min at 37°C in medium containing 5 lM JC-1 dye. Emitted green (535 nm) and red (595 nm) fluorescence intensities were analyzed by CLARIOstar multi-mode microplate reader and ratiometric comparative fluorescence of the two were plotted using PRISM 5.1 (GraphPad Software, La Jolla, CA, USA) as illustrated.
Gene expression analysis by quantitative real-time PCR
Total RNA was isolated from cells using a SV total RNA isolation kit by following the manufacturer's protocol (Promega, Z3105). To synthesize the cDNA, the superscript III first-strand synthesis system (Thermo Fisher Scientific) was used. Gene expression analysis was done with quantitative real-time PCR using SYBR Green PCR master mix (4367659, Thermofisher Scientific). Primers used for gene expression analysis are listed in Table S1 .
Statistics analysis
The statistical significance of the difference between mean values was tested using an unpaired Student's t test. Data are represented as means AE SEM of at least three independent experiments. 
Supporting information
Additional Supporting Information may be found online in the supporting information tab for this article: Table S1 . Primers of quantitative real-time polymerase chain reaction (PCR) used in the study.
